Sprycel (dasatinib tablets - Bristol-Myers Squibb; generic) — Cigna

Initial criteria

• Approve for 1 year if BOTH of the following (A and B) are met:
• A) Patient age ≥ 18 years; AND
• B) Patient has tried imatinib or Ayvakit (avapritinib tablets).

Approval duration

1 year